Related Experiment Video
Updated: Apr 28, 2026

10:21
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
9.9K
Cardiac fibroblasts in pressure overload hypertrophy: the enemy within?
The Journal of Clinical Investigation
|June 18, 2014
Summary
Cardiac fibroblast accumulation in heart disease primarily stems from resident fibroblast proliferation, originating from the epicardium and endocardium. Understanding these origins is key for developing new cardiac therapies.
Area of Science:
- Cardiovascular Biology
- Fibroblast Biology
- Cardiac Pathophysiology
Background:
- Cardiac fibroblasts are implicated in heart disease, but their roles are unclear due to a lack of specific markers.
- Identifying fibroblast origins is crucial for understanding their contribution to cardiac remodeling and disease progression.
Purpose of the Study:
- To investigate the origin and proliferation of cardiac fibroblasts in response to pressure overload.
- To identify novel sources of fibroblasts contributing to cardiac disease.
Main Methods:
- Utilized a collagen1a1-green fluorescent protein (GFP) reporter mouse model for fibroblast lineage tracing.
- Induced cardiac pressure overload via aortic banding in mice.
- Analyzed fibroblast proliferation and origin using histological and molecular techniques.
Main Results:
- Fibroblast accumulation after aortic banding predominantly resulted from the proliferation of resident fibroblasts.
- Identified both the epicardium and a previously unrecognized source, the endocardium, as origins of these proliferating fibroblasts.
- Demonstrated distinct contributions of epicardial and endocardial fibroblasts to cardiac remodeling.
Conclusions:
- Resident fibroblasts, originating from both epicardium and endocardium, are the primary source of fibroblast expansion during cardiac pressure overload.
- This study uncovers the endocardium as a significant, previously unrecognized source of cardiac fibroblasts.
- Further research into fibroblast origin and function can inform the development of targeted cardiac therapies.
Related Concept Videos
Heart Failure II: Pathophysiology
1.7K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Cellular Adaptation II: Hypertrophy
49
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy:...
49
Cardiomyopathy III: Hypertrophic Cardiomyopathy
801
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Introduction to Fibroblasts
3.9K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.9K
Structure of Cardiac Muscles
16.6K
Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
16.6K
Pathophysiology of Heart Failure
4.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K

